-
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
17 Jun 2025 12:00 GMT
… David M. Rubenstein Center for Pancreatic Cancer, and is an Attending Physician … and genetic-based therapies for pancreatic cancer, along with the development of … in patients with mKRAS-positive pancreatic cancer who completed standard therapy but …
-
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
17 Jun 2025 10:00 GMT
… paclitaxel (mGnP) in first-line pancreatic cancer patients. “These exceptional data demonstrate … more durable treatment option for pancreatic cancer patients, for whom limited … with advanced solid tumors including pancreatic cancer. The Company’s development …
-
ClearNote Health initiates study of test to detect early pancreatic cancer
17 Jun 2025 11:49 GMT
… by University Hospital Southampton consultant pancreatic cancer surgeon Zaed Hamady.
It will … elevated-risk group.
The Avantect Pancreatic Cancer Test targets individuals at risk … its Avantect test could identify pancreatic cancer in high-risk individuals, …
-
Compensation payout of 260,000 euros to son for death of woman wrongly diagnosed with pancreatic cancer in Spain
17 Jun 2025 11:10 GMT
… who was wrongly diagnosed with pancreatic cancer when, in fact, she suffered … -old woman was diagnosed with pancreatic cancer at the Hospital Santa Bárbara … more serious disease: bowel cancer.
The cancer grew uncontrollably and the patient …
-
Immuneering reports Phase 2a MEK pill data in first-line pancreatic cancer
17 Jun 2025 10:06 GMT
-
UK doctors trial blood test to detect early signs of pancreatic cancer
17 Jun 2025 05:44 GMT
… accurate in identifying early-stage pancreatic cancer, which claims almost 10,000 … predisposition or family history of pancreatic cancer.
Sean Cleghorn's wife … Macdonald, head of research at Pancreatic Cancer UK, said: "Early findings …
-
Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer
17 Jun 2025 11:00 GMT
… of the Head and Neck Cancer Program, and the Principal … or metastatic head and neck cancer, who do not respond … for the treatment of multiple cancer indications. As proof of concept … study for the treatment of pancreatic ductal adenocarcinoma (PDAC) with …
-
NextGen MURR secures $50 million in funding to propel cancer treatment research
17 Jun 2025 09:49 GMT
… Mizzou and its impact on cancer treatment.
"If … Last year, 450,000 cancer patients were treated with isotopes … art reactor, would expand cancer treatment capabilities by allowing … treat thyroid, liver, pancreatic and prostate cancers, the existing MURR …
-
You might be interested in…GI Cancers
17 Jun 2025 07:42 GMT
… Zealand for colorectal cancer, and Western Europe for pancreatic cancer.
The lifetime … increased in colorectal cancer, pancreatic cancer and liver cancer from steatotic liver … association between alcohol intake and pancreatic cancer risk, irrespective of sex …
-
Wisconsin man riding motorcycle to Alaska to raise money for pancreatic cancer clinical trials
17 Jun 2025 02:51 GMT
… to help raise money for pancreatic cancer research.
On Friday, 69- … aims to raise awareness for pancreatic cancer as well as funds for … he was diagnosed with pancreatic cancer back in August of … groups, with a focus on pancreatic cancer, to fund research and …